Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
2.800
-0.150 (-5.08%)
At close: Nov 20, 2024, 4:00 PM
2.820
+0.020 (0.71%)
Pre-market: Nov 21, 2024, 7:12 AM EST
Autolus Therapeutics Market Cap
Autolus Therapeutics has a market cap or net worth of $745.14 million as of November 21, 2024. Its market cap has increased by 15.78% in one year.
Market Cap
745.14M
Enterprise Value
389.25M
1-Year Change
15.78%
Ranking
Category
Stock Price
$2.80
Market Cap Chart
Since June 22, 2018, Autolus Therapeutics's market cap has decreased from $969.66M to $745.14M, a decrease of -23.15%. That is a compound annual growth rate of -4.02%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Embecta | 832.06M |
Liquidia | 831.13M |
Healthcare Services Group | 823.06M |
Relay Therapeutics | 818.50M |
Tyra Biosciences | 817.93M |
Cullinan Therapeutics | 783.16M |
AbCellera Biologics | 782.72M |
Avanos Medical | 782.08M |